News
PAHC
55.52
+1.39%
0.76
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
NASDAQ · 2d ago
Zacks Investment Ideas feature highlights Phibro, Deluxe, Remitly and BrightSpring
NASDAQ · 3d ago
Phibro Animal Health CEO Jack Bendheim disposes of $0.76 million common shares
Reuters · 3d ago
4 Small Cap Stocks with Outstanding Fundamentals and Momentum
NASDAQ · 3d ago
Weekly Report: what happened at PAHC last week (0323-0327)?
Weekly Report · 5d ago
Reasons to Retain Penumbra Stock in Your Portfolio for Now
NASDAQ · 03/27 12:49
Phibro Animal Health; President and CEO Jack Bendheim disposes of common shares worth $1,171,000
Reuters · 03/27 01:19
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data
NASDAQ · 03/26 16:03
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
NASDAQ · 03/26 13:08
PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative
NASDAQ · 03/26 13:05
Should You Retain Henry Schein Stock in Your Portfolio for Now?
NASDAQ · 03/26 12:14
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B
Seeking Alpha · 03/25 16:31
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
NASDAQ · 03/25 12:21
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
Barchart · 03/25 02:32
Best "Strong Buy" Momentum Stocks to Buy Now and in April
NASDAQ · 03/24 20:08
Here's Why You Should Retain GEHC Stock in Your Portfolio for Now
NASDAQ · 03/24 16:22
Weekly Report: what happened at PAHC last week (0316-0320)?
Weekly Report · 03/23 09:35
Should You Continue to Hold Insulet Stock in Your Portfolio?
NASDAQ · 03/20 16:31
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
NASDAQ · 03/19 15:30
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know
Barchart · 03/16 15:20
More
Webull provides a variety of real-time PAHC stock news. You can receive the latest news about Phibro Animal through multiple platforms. This information may help you make smarter investment decisions.
About PAHC
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.